Young David 4
4 · Processa Pharmaceuticals, Inc. · Filed Jul 28, 2025
Insider Transaction Report
Form 4
Young David
DirectorPres. Research & Development
Transactions
- Award
Restricted Stock Units
2025-07-24+1,813,133→ 1,821,016 totalExercise: $0.00→ Common Stock (1,813,133 underlying)
Footnotes (2)
- [F1]Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,790,833 shares are subject to stockholder approval of the revised Omnibus Plan.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.